Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.
about
Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseMesenchymal stem cells and immunomodulation: current status and future prospectsStem cell-based regenerative opportunities for the liver: State of the art and beyondMesenchymal stem cell therapy for liver fibrosisTherapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysisAutologous bone marrow transplantation in decompensated liver: Systematic review and meta-analysisBone marrow derived stem cells for the treatment of end-stage liver diseaseAutologous bone marrow-derived cells in the treatment of liver disease patientsConcise review: bone marrow autotransplants for liver disease?Systematic review: the effects of autologous stem cell therapy for patients with liver diseaseRole of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure.Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferationUse of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury.Different characteristics of mesenchymal stem cells isolated from different layers of full term placenta.Therapeutic potential of mesenchymal stem cells in regenerative medicineEx Vivo Stromal Cell-Derived Factor 1-Mediated Differentiation of Mouse Bone Marrow Mesenchymal Stem Cells into Hepatocytes Is Enhanced by Chinese Medicine Yiguanjian Drug-Containing Serum.Effect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis.Stem cells in liver regeneration and their potential clinical applications.Immunological basis of stem cell therapy in liver diseases.Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review.Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials.Stem Cell Therapy: Current Applications and Potential for Urology.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Molecular Imaging of Stem Cell Transplantation for Liver Diseases: Monitoring, Clinical Translation, and Theranostics.Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis.Progress in stem cell-based therapy for liver disease.Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma.Therapeutic application of multipotent stem cells.In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential.In vivo hepatogenic capacity and therapeutic potential of stem cells from human exfoliated deciduous teeth in liver fibrosis in mice.Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease.Cell-Based Therapies for Tissue Fibrosis.Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.A case report of congenital glycogen storage liver cirrhosis treated with bone marrow derived stem cells.Stem cell therapy for the treatment of parasitic infections: is it far away?Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study.Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.
P2860
Q26769618-A860A9A5-3EC1-40F9-928B-C434B83D220FQ26770191-17D5E104-C464-4ACE-B5A3-90E7CD960576Q26775924-D3E97CCE-FD7E-41AD-9A22-35F47BADDFC8Q26782128-5102A540-66F3-4174-A454-442E1D7572E1Q26783606-E04AC841-F7B8-4A82-B425-CAA8235B3BE4Q26801163-33B108B5-A3D5-47D2-845A-94C1BC87499AQ26850412-B8D0F47D-6127-41E3-A451-E7685BF9F627Q26863284-8603CA29-A972-4AA6-9F8A-A9C975C463B0Q27010009-DBFC229A-D595-4F4A-AFF2-7367B0F67EC3Q27024968-72F8D21A-C2CE-46F8-8595-4CE233689928Q33767742-8C8081F0-3A0A-4446-B655-949213BA967FQ34194760-38E2D71A-F6E2-418B-A361-DEC78F1CA3E4Q34516477-0ADC7A1E-E8B8-4A32-A127-4095B3F0F11BQ34985947-783BE854-A5BB-48A6-B42D-9F71C9D3BC37Q35409945-45DF825E-006B-4EAD-862E-737BB22DEBEFQ36287523-E68F5A5D-12DD-4555-8B47-7764157A4B29Q36737833-E59F792A-B2BF-457A-A396-E98ECD0E9339Q36845499-880D2002-5F00-482D-B1E1-CCF5E7DE998DQ37654580-ACCF99B1-10F5-4BD7-8270-FD7617267F20Q38092746-D7D1E892-6A41-4FB7-8091-2152B3D26D65Q38223210-07A68ACC-F0FF-4F5B-8084-2B24904C3DE1Q38393820-0885BA2D-2EE9-459D-A68E-8D9733E786D4Q38414766-4BF99077-9928-4EBA-8F79-553DB8413D06Q38589422-89422ADD-C5E8-4DF7-A63D-46C8FBBD5362Q38675565-E21DA8AD-0222-45B9-BB1D-4B5E39575104Q38772557-E3DD68D4-92ED-4058-8F03-0634C91CAAB3Q38820953-A3ED691C-1075-4838-8E6E-F13BE98DEE4AQ38836460-5BB90075-035C-4427-9E53-2129E6F8636BQ39143427-3564A63F-D361-492B-A0AC-ED8BF38EEBD9Q39285733-3E883690-156D-46DF-BB3A-2F601B1909EFQ39410484-BA1B59C0-66D5-4642-B2BC-237D8B1E33A3Q39441667-7087B989-7D51-4037-AABB-3F7EB2AFB2B8Q41922753-F808AFEB-1770-4D8B-99BF-AF132296E58FQ42211281-A6CF04D1-DA9C-4748-A129-97C327783803Q42369905-5DD908F6-FE31-4CD4-8E0E-DB66B71DC48EQ42585736-E9B8C041-1E72-4F27-8782-DA1D2DB736A7Q42800214-87DAF811-CCE5-47BE-B2D0-6DBE6C92EB3DQ44115782-AE915ECC-B702-4C9C-AD9F-F850C1748957Q46177862-825C192C-8073-4834-B4D6-6482EEE2CF84Q47150689-3940DC60-0D61-463B-98B1-1D946AEAB12B
P2860
Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.
@en
type
label
Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.
@en
prefLabel
Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.
@en
P2093
P2860
P1476
Phase II trial: undifferentiat ...... h HCV induced liver cirrhosis.
@en
P2093
Iman Abdel-Aziz
Marwa Wahdan
Mervat El-Ansary
Olfat Hammam
Salwa Teaema
Samah Abdel-Hamid
Sherif Mogawer
P2860
P2888
P304
P356
10.1007/S12015-011-9322-Y
P577
2012-09-01T00:00:00Z
P6179
1026199217